Concourse Financial Group Securities’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6756 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7337 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7334 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7343 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7341 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7274 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7105 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6937 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6687 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6701 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6524 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6462 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6340 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6284 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6094 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5885 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5687 |
|